- Home
- UDR vs BMRN Comparison
UDR vs BMRN Comparison
Compare UDR & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDR
- BMRN
- Stock Information
- Founded
- UDR 1972
- BMRN 1996
- Country
- UDR United States
- BMRN United States
- Employees
- UDR N/A
- BMRN N/A
- Industry
- UDR Real Estate Investment Trusts
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- UDR Real Estate
- BMRN Health Care
- Exchange
- UDR Nasdaq
- BMRN Nasdaq
- Market Cap
- UDR 13.7B
- BMRN 12.1B
- IPO Year
- UDR N/A
- BMRN 1999
- Fundamental
- Price
- UDR $40.98
- BMRN $55.65
- Analyst Decision
- UDR Hold
- BMRN Buy
- Analyst Count
- UDR 14
- BMRN 22
- Target Price
- UDR $46.29
- BMRN $93.43
- AVG Volume (30 Days)
- UDR 2.3M
- BMRN 2.2M
- Earning Date
- UDR 07-29-2025
- BMRN 08-04-2025
- Dividend Yield
- UDR 4.21%
- BMRN N/A
- EPS Growth
- UDR N/A
- BMRN 152.82
- EPS
- UDR 0.36
- BMRN 2.71
- Revenue
- UDR $1,705,220,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- UDR $1.05
- BMRN $12.23
- Revenue Next Year
- UDR $3.49
- BMRN $9.99
- P/E Ratio
- UDR $113.85
- BMRN $20.77
- Revenue Growth
- UDR 2.11
- BMRN 19.36
- 52 Week Low
- UDR $36.61
- BMRN $52.93
- 52 Week High
- UDR $47.55
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- UDR 44.50
- BMRN 40.03
- Support Level
- UDR $40.01
- BMRN $53.76
- Resistance Level
- UDR $41.18
- BMRN $55.96
- Average True Range (ATR)
- UDR 0.68
- BMRN 1.17
- MACD
- UDR -0.04
- BMRN 0.09
- Stochastic Oscillator
- UDR 27.51
- BMRN 26.00
About UDR UDR Inc.
UDR Inc is a real estate investment trust that owns, operates, acquires, renovates, develops, redevelops, disposes of, and manages multifamily apartment communities in targeted markets located in the United States. The company has two reportable segments; Same-Store Communities segment represents those communities acquired, developed, and stabilized; and Non-Mature Communities/Other segment represents those communities that do not meet the criteria to be included in Same-Store Communities, including, but not limited to, recently acquired, developed and redeveloped communities, and the non-apartment components of mixed-use properties. It generates key revenue from Same-Store Communities.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.